DTL
CGEM icon

Dynamic Technology Lab’s Cullinan Oncology CGEM Stock Holding History

Dynamic Technology Lab’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,581
Closed -$163K – 983
2025
Q1 		$163K Buy
+21,581
New +$207K 0.02% 859

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Dynamic Technology Lab's CGEM Position: Q2 2025 in Review

Dynamic Technology Lab sold out of Cullinan Oncology (CGEM) in Q2 2025, closing a stake of 21,581 shares — an estimated $163K sold.

Dynamic Technology Lab first reported a position in CGEM in Q1 2025 and held it in 1 quarter. The position peaked at $163K in Q1 2025. 143 funds tracked by Wall St. Rank hold CGEM as of Q2 2025.

  • Dynamic Technology Lab reported no remaining Cullinan Oncology position as of Q2 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 21,581 Cullinan Oncology shares in Q2 2025, an estimated $163K.
  • Dynamic Technology Lab first reported a position in Cullinan Oncology in Q1 2025 and held it in 1 quarter.
  • Dynamic Technology Lab's Cullinan Oncology position peaked at $163K in Q1 2025.
  • 143 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2025.

Based on Dynamic Technology Lab's 13F filing for Q2 2025, filed 12 Aug 2025.